RHOT1 and cancer: Utilizing an osteocyte conditional MIRO1 knockout (MIRO1CKO) mouse model, MIRO1CKO mice developed larger bone metastases, concurrent with fewer mitochondria transferred from osteocytes to the cancer cells.